medroxyprogesterone acetate has been researched along with Gall Bladder Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, GL; Aragaki, AK; Banack, H; Chlebowski, RT; Gass, M; Manson, JE; Prentice, RL; Qi, L; Rossouw, JE; Shadyab, AH; Snively, BM; Wallace, R; Zhao, S | 1 |
| Cirillo, DJ; Greenland, P; LaCroix, AZ; Larson, JC; Limacher, MC; Rodabough, RJ; Wallace, RB | 1 |
| Emory, LE; Meyer, WJ; Smith, ER; Walker, PA | 1 |
1 trial(s) available for medroxyprogesterone acetate and Gall Bladder Diseases
| Article | Year |
|---|---|
Effect of estrogen therapy on gallbladder disease.
Topics: Aged; Cholecystectomy; Cholecystitis; Cholelithiasis; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gallbladder Diseases; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Proportional Hazards Models; Risk Factors | 2005 |
3 other study(ies) available for medroxyprogesterone acetate and Gall Bladder Diseases
| Article | Year |
|---|---|
Dual-Outcome Intention-to-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials.
Topics: Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Gallbladder Diseases; Humans; Incidence; Intention to Treat Analysis; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; United States | 2020 |
Postmenopausal hormone therapy offers no protection against heart attacks.
Topics: Aged; Controlled Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gallbladder Diseases; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Placebos; Postmenopause; Progesterone Congeners; Progestins; Randomized Controlled Trials as Topic; Risk Factors; Thrombosis; Time Factors | 2002 |
Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate.
Topics: Adult; Blood Pressure; Body Weight; Follicle Stimulating Hormone; Gallbladder Diseases; Glucose Tolerance Test; Hematologic Tests; Humans; Injections, Intramuscular; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Paraphilic Disorders; Penis; Semen; Sperm Count; Sperm Motility; Testis; Testosterone; Time Factors | 1985 |